1.02%
0.93EUR
69.612MEUR
683.881MEUR
69.488M
About FAGRON
Sector
Industry
CEO
Rafael Padilla Papaceit
Website
Headquarters
Nazareth
Employees (FY)
3.035K
Founded
1990
ISIN
BE0003874915
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. It operates through the following segments: Essentials, Brands, and Compounding Services. The Essential segment focuses on supplying raw materials to community and hospital pharmacies for pharmaceutical compounding. The Brands segment is involved in developing and producing semi-finished products and vehicles, such as emulsions, powder mixtures, creams, and other excipients, as well as total concepts and equipment for pharmaceutical compounding. The Compounding Services segment offers community and hospital pharmacies with ready-to-use non-sterile compounded medicine in those countries where it is permitted. The company was founded in 1990 and is headquartered in Nazareth, Belgium.
Fagron: positive divergence in specific indicatorsIf we have a look to the negative divergence in at least 2 of the 3 indicators, we can see that shares of the Fagron Group were pushed down. Then we saw a massive positive divergence which resulted in a giant bouce. With impressive spikes, the momentum ran out of upside power. At this very moment we
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
